Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset
暂无分享,去创建一个
M. Plebani | P. Gallo | G. Pantano | G. De Silvestro | A. Zito | M. Puthenparampil | S. Miante | L. Federle | E. Stropparo | Erica Stropparo | Giorgia Pantano
[1] P. Gallo,et al. Evidence of B-cell dysregulation in severe CNS inflammation after alemtuzumab therapy , 2017, Neurology: Neuroimmunology & Neuroinflammation.
[2] T. Marquez-Lago,et al. Dynamic regulation of T Follicular Regulatory cell responses by interleukin 2 during influenza infection , 2017, Nature Immunology.
[3] A. E. Sousa,et al. Human blood Tfr cells are indicators of ongoing humoral activity not fully licensed with suppressive function , 2017, Science Immunology.
[4] L. Graça,et al. T follicular regulatory cells in mice and men , 2017, Immunology.
[5] A. Traboulsee,et al. Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis , 2017, The New England journal of medicine.
[6] Bernhard Hemmer,et al. Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis , 2017, The New England journal of medicine.
[7] H. Wekerle. B cells in multiple sclerosis , 2017, Autoimmunity.
[8] A. DeFranco. The germinal center antibody response in health and disease , 2016, F1000Research.
[9] I. Maclennan,et al. Follicular Helper T Cells. , 2016, Annual review of immunology.
[10] A. Sharpe,et al. T follicular regulatory cells , 2016, Immunological reviews.
[11] G. Papp,et al. A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus , 2016, Clinical and experimental immunology.
[12] M. Hecker,et al. Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients. , 2015, Autoimmunity reviews.
[13] N. Hellings,et al. Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis , 2015, The Journal of Immunology.
[14] T. Jin,et al. Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis , 2015, PloS one.
[15] S. Crotty. A brief history of T cell help to B cells , 2015, Nature Reviews Immunology.
[16] U. Klein,et al. Dynamics of B cells in germinal centres , 2015, Nature Reviews Immunology.
[17] Philip D. Hodgkin,et al. The generation of antibody-secreting plasma cells , 2015, Nature Reviews Immunology.
[18] L. Ma,et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new‐onset rheumatoid arthritis , 2013, Clinical and experimental immunology.
[19] H. D. de Vries,et al. Grey matter damage in multiple sclerosis , 2013, Prion.
[20] R. Reynolds,et al. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. , 2012, Brain : a journal of neurology.
[21] V. Kuchroo,et al. Immune checkpoints in central nervous system autoimmunity , 2012, Immunological reviews.
[22] J. Craft. Follicular helper T cells in immunity and systemic autoimmunity , 2012, Nature Reviews Rheumatology.
[23] J. Craft,et al. T cells that promote B‐Cell maturation in systemic autoimmunity , 2012, Immunological reviews.
[24] B. Scheithauer,et al. Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.
[25] R. Reynolds,et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. , 2011, Brain : a journal of neurology.
[26] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[27] R. Reynolds,et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis , 2010, Annals of neurology.
[28] E. Frohman,et al. Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.
[29] Hansotto Reiber,et al. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs , 2001, Journal of the Neurological Sciences.
[30] Moses Rodriguez,et al. Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.
[31] E. Thompson,et al. Serum oligoclonal IgG is a common and persistent finding in multiple sclerosis, and has a systemic source. , 1996, QJM : monthly journal of the Association of Physicians.
[32] G. Bernardi,et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[33] W. Tourtellotte,et al. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis , 1986, The Journal of experimental medicine.
[34] I A Mjör,et al. Consensus Report , 1985, Journal of dental research.
[35] T. Olsson,et al. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. , 1984, Clinical chemistry.
[36] G. Tibbling,et al. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.